Expert panel - Video

Case-Based Discussions Focused on the Management of NHL/CLL| Research To Practice http://bit.ly/14b2GeE 

Experts on case management.

Intended audience- oncologists. About as good as it gets.

Leonard - Follicular
Dreyling - MCL
Czuczman - DLBCL
Horwitz - T-cell lymphoma
Smith - CLL

Haematologica. 2013 Jun 10.: High cure rates in Burkitt lymphoma and leukemia: NILG study of the German short intensive rituximab-chemotherapy program. http://1.usa.gov/12AKHRQ 

Oncology TImes: CLL: ‘Potent,‘ Well-Tolerated Activity for Ibrutinib, Irrespective of Deletion 17p http://bit.ly/17kh2hJ

Sunrise Rounds: Why is the doctor ANGRY? http://bit.ly/18GhTqZ 

Dr Len's Cancer blog: Genomics And Personalized Medicine: Is It Really Different This Time? http://bit.ly/11vyhEt 

Dr. Sharman's CLL & Lymphoma Blog Personalized Medicine - turning drug development upside down! http://bit.ly/18GBcTq 

Psychology Today: 12 Tips from 12 Years Sick http://bit.ly/1aKOR8J 

The onc: Are Oncology Studies Really Less Robust? http://bit.ly/Zzc3am 

NPR: Cherishing The Gift Of Friendship Through A Cancer Bout http://n.pr/11cDvpC 

News Medical: Three easy steps for cancer survivorship http://bit.ly/11Hx96w 

NYT: Life, Interrupted: Going Public With Cancer http://nyti.ms/140Xmwl 

Medpage Today: Combo Boosts PFS as Initial Leukemia (CLL)Therapy http://bit.ly/11q3FUM 

Cancer.net: What to Know: ASCO's Guideline on Fertility Preservation http://bit.ly/15aFkak 

Sunrise Rounds: Doc, how about some marijuana? http://bit.ly/12OJouy 

News Medical; Survival rates increased among patients who received blood stem cell transplants: Study http://bit.ly/1az7qwL 

Science-Based Medicine: Patient Participation in Decision-Making http://bit.ly/1599OK6 

Respectful Insolence: Cutting, poisoning, and burning naturally http://bit.ly/11p0nBh 

OncLive: Primary Management of Advanced Hodgkin Lymphoma http://bit.ly/12ZlCxC 

MNT: Intensified, Liposomal Anthracycline-Based Chemo Regimen For Children With Leukemia May Offer High Survival Rates Without Added Heart Toxicity http://bit.ly/1asgweF

NYTimes: Battling Cancer Together http://nyti.ms/11sLPWY 

MailOnline: The mother and daughter diagnosed with the SAME cancer (hodgkins) at exactly the SAME age - even though it's not hereditary http://bit.ly/11lGSte 

MedicalXpress: Non-Hodgkin lymphoma survival doubles since early 1970s http://bit.ly/14Fh6ov 

Science Daily: It's Not Your Imagination: Memory Gets Muddled at Menopause http://bit.ly/ZhsdVL
 
Some women get thrown in to menopause from treatment....is it chemobrain or menopause, combination?

Medscape: After Cancer: Debate About Terminology Beyond Treatment http://bit.ly/16Y1Nvu

NYT: Mothers With Cancer http://nyti.ms/11epTZI 

Huff Post: Medical No Man's Land: A 20-year-old Cancer Patient http://huff.to/16RxgyD 

NYT: What's in Your Green Tea? http://nyti.ms/10OaO17 

Cancer and careers: Working with Chemo Brain http://bit.ly/10RtUrm

Onclive: ONLINE FIRST: In Phase I Study, CLL Patients Appear to Benefit from Isoform-Specific PI3K Inhibitor http://bit.ly/168zCK9 

Dr. Sharman's CLL & Lymphoma Blog: Inotuzumab sinks.... http://bit.ly/10PI108 

Reuters: Pfizer halts study of lymphoma drug unlikely to help survival http://reut.rs/13GKNpE

inotuzumab ozogamicin

Comments: A good example of a "failed" controlled study that provides valuable information. Without the randomized design and the comparator ... the results may have seemed "encouraging" or "deserving of further study." IO may still find its place as an effective lymphoma treatment (such as in consolidation or in indolent lymphoma). Relapsed / refractory aggressive lymphoma ineligible for SCT is a challenging setting and it seems that chemo has an edge over antibody therapy in this population (based on RIT for example) - perhaps because chemo is faster acting?

Science Daily: Radioactive Nanoparticles Target Cancer Cells http://bit.ly/16N4LCr 

Sunrise Rounds: Don’t play the numbers http://bit.ly/12J3CYi 

MNT: Cancer Survivors Suffer Physical & Emotional Impairments Which Often Go Untreated http://bit.ly/1a0imTH 

Dr. Sharman: How expensive are new drugs? http://bit.ly/10zY11Z

April 2013: Pharmacyclics Completes Enrollment of Phase III Ibrutinib CLL Study and Phase II Ibrutinib MCL Study  ascopost.com

Latif and Morris: Monoclonal Antibody Therapy of T-Cell Leukemia and Lymphoma:  http://bit.ly/WimCgm

Oncology Times: Stage I Follicular Lymphoma: LymphoCare Study Questions Role of Radiation—Many Options, ‘Rigorous’ Staging Key http://bit.ly/O6rWhP

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? http://1.usa.gov/S2hWsi

Parenthood in Survivors of Hodgkin Lymphoma: An EORTC-GELA General Population Case-Control Study. http://1.usa.gov/RkQTWB

Doctors Lounge: Watch & Wait OK in Low-Tumor Burden Follicular Lymphoma http://bit.ly/Sl49va

Watchful Waiting in Low-Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database. http://1.usa.gov/P9pAdW 

Dr. Cheson on expectant management of follicular lymphoma: Waiting is the Hardest Part http://bit.ly/Sm3plQ

oNLINE FIRST: Stage I Follicular Lymphoma: LympoCare Study Questions Role of oncology Times: Radiation; Many Options, ‘Rigorous’ Staging Key http://bit.ly/NuPdda

OncLive: Dr. Furman on Trials Examining Ibrutinib's Safety in CLL http://bit.ly/VPeLF7

Cancer Connect: Cystitis from treatments http://bit.ly/10ndcRH  Tips on how to avoid it etc

NBC: If you can't pay: How to get insurance to cover specialty drugs http://nbcnews.to/SfsNiu

Dr. Sharman's CLL & Lymphoma Blog What is R-CHOP?

Dr. Sharman's CLL & Lymphoma Blog: What is FCR? http://bit.ly/PBQkI6 

An excellent explanation. A good read- even if your battle is not with CLL.

HemOnc Today: Optimized fertility advice needed for Hodgkin's lymphoma survivors http://bit.ly/U2KmjV

Dr. Sharman's CLL & Lymphoma Blog: Making sense of all the different lymphomas  http://bit.ly/OfCYNs

MNT: Improving Cell-Based Immune Therapies For Cancer http://bit.ly/VaFLxN Exciting concept

ASH Education, 2012:
The many faces of marginal zone lymphoma
by Dr. Zinzani  http://bit.ly/TTcdUk  

ASH Education, 2012:
Is there a role for "watch and wait" in follicular lymphoma in the rituximab era? by Dr. Brad Kahl
http://bit.ly/U40lNi 

Medscape: Is R-Benda a New Standard in Lymphoma? http://bit.ly/X5Azh5 

KevinMD.com: How to get the most out of your oncology appointments http://bit.ly/Wts8Xs

Dr. Sharman's CLL & Lymphoma Blog:
Richter's Syndrome / Histologic Transformation: Richter's Syndrome / Histologic Transformation http://bit.ly/UQj6al

Medscape: Fatigue-Busting Programs Work Even in Advanced Cancer http://bit.ly/X6O9gV

NYT: Living With Cancer: Chemo-Feet (peripheral neuropathies) http://nyti.ms/100QEqw

Cancer Connect: Prophylactic Vorinostat Cuts Risk of Graft-Versus-Host Disease in Half http://bit.ly/VGbpQJ

ASH abstract: https://ash.confex.com/

Medscape: A Call to Eliminate 'Chemotherapy Concession' http://bit.ly/RtRuHz

KevinMD: Are you a thrifty patient? How to get the care you need and save money http://bit.ly/W3P4vu

KevinMD.Com: How to deliver bad news to patients: 9 tips to do it better http://bit.ly/Uljp9A

On Healthy Survivorship: Tips for Adult Children of Newly Diagnosed Patients http://bit.ly/X0OJww

Science Based Medicine: Beyond Informed Consent: Shared Decision-Making http://bit.ly/TuK9XV

Dr Sharman's CLL and Lymphoma Blog: The Slow (Indolent) Lymphomas http://bit.ly/VqwvmE

Thank you Dr Sharman for this patient friendly explanation!

Sunrise Rounds: 100% Inconclusive http://bit.ly/XeN9Lu
MSNBC: How to avoid spreading the flu: Stay home for 4 days http://nbcnews.to/WXacGF

NYT: Juggling Diabetes and Cancer http://nyti.ms/Vfv0YM  excellent article

Health News Reviews:
3rd annual year-ender on health care Public Relations crap we receive http://bit.ly/UEmQfg 

KevinMD.Com: Physicians can be better doctors by being patients http://bit.ly/ZPnuuz

Forbes: Making a Profit from Offering Ineffective Therapies to Cancer Patients http://onforb.es/XaKKkN

Dr. Sharman's CLL & Lymphoma Blog :
New CLL Prognostic Groups http://bit.ly/Vo0X3u

Science Daily: New Technique Catalogs Lymphoma-Linked Genetic Variations http://bit.ly/10kVmOM

NEJM: The Impact of Drug Shortages on Children with Cancer — The Example of Mechlorethamine http://bit.ly/TyYyEz

Science Daily: Immune System Changes May Drive Aggressiveness of Recurrent Tumors
http://bit.ly/Vj72OE

Science Based Medicine: Why Do People turn to Alternative Medicine http://bit.ly/U9vHSn

Onc Times: View from the Other Side of the Stethoscope: False Hope http://bit.ly/Tp5wsf

CNN: Why I donated my bone marrow http://bit.ly/U8apo8 

Lymphoma patients cannot make donations but can encourage others to do so!

New Yorker: Cleaning up Science: http://nyr.kr/VZsB30

Visco C. J Clin Oncol.2013
R-BAC shows promise in mantle cell lymphoma PAL 

Medical Imaging: Safety Resources
compiled by PAL

Dr. Wierda and Practical Advice on CAR-T Trials PAL

Onc Times: Fatigue: The Forgotten Symptom? PAL

Conflict of interest in medical decision making PAL

Programming T-cells to work like antibodies PAL

Dr. Sharman's CLL & Lymphoma Blog:
Choosing first therapy in CLL http://bit.ly/13vDKTa 

Medpage today: Combo Tx Gets Perfect Score in Mantle Cell Lymphoma http://bit.ly/12OInDA

Maintenance Rituxan for lymphoma: Pros, Cons, Uncertainties - PAL

Medication Organizer - print out and use to help reduce medical errors - PAL PDF

ASCO 2013 report on Mogo - targeting CCR4 for some t-cell lymphomas PAL

Dr. Sharman's CLL & Lymphoma Blog
Follicular Lymphoma Grade and Stage http://bit.ly/17o8Kkl

Dr. Sharman's CLL & Lymphoma Blog: On
“stereotyped” B cell receptors and how this drives CLL:  http://bit.ly/140RvWX 

JCO - O. Press: Selection of First-Line Therapy for Advanced Follicular Lymphoma PAL

AACR: Risk of Infection-Related Cancers after the Loss of a Child: A Follow-up Study in Sweden PAL

HemOnc Today: Optimized fertility advice needed for
Hodgkin's lymphoma survivors PAL

PAL: 7 Big Picture Questions Guiding the Approach to treatment http://bit.ly/13PB9Rm  Updated brochure

PAL: CONSIDERING CLINICAL TRIALS based on your unique clinical circumstances http://bit.ly/WrzUSI  updated brochure

PD-1 antibody for follicular lymphoma? PAL

Vitamin C and Cancer: What can we conclude 1609 patients and 33 years later   PAL

About btk-inhibitors by PAL

Perspective on the Importance of the Clinical Context

Diet as TREATMENT for lymphoma?

Find NCI-Designated Cancer Centers using Map

First line Studies for DLBCL, grouped by categories

Maintenance Rituxan - perspectives and reports 

State laws for insurance covering routine costs in trials